Skip to main content

Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) Investor Investigation Concerning Potential Wrongdoing In Acquisition

  • If you purchased shares of Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) and currently hold any of those NASDAQ:CADX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

February 11, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) shares, was announced concerning whether the takeover of Cadence Pharmaceuticals, Inc. by Mallinckrodt plc for $14.00 per share is unfair to NASDAQ:CADX stockholders. The investigation by a law firm concerns whether certain off...



You must register (for free) or login to view the entire investigation.